LT
The startup develops targeted therapeutic methods that focus on pathogenic auto-antibodies, conducting research to understand the pathology of diseases linked to these antibodies. By creating specific treatments, the company aims to enhance patient health outcomes in conditions driven by auto-antibody activity.
Kyoto, Japan
Updated 2 months ago
Funding
$2.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops targeted therapeutic methods that focus on pathogenic auto-antibodies, conducting research to understand the pathology of diseases linked to these antibodies. By creating specific treatments, the company aims to enhance patient health outcomes in conditions driven by auto-antibody activity.